These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32445489)

  • 41. COVID-19 and the liver: the chicken or the egg dilemma.
    Ampuero J; Romero Gómez M
    Rev Esp Enferm Dig; 2021 Jul; 113(7):555. PubMed ID: 33569963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is liver involvement overestimated in COVID-19 patients? A meta-analysis.
    Li G; Yang Y; Gao D; Xu Y; Gu J; Liu P
    Int J Med Sci; 2021; 18(5):1285-1296. PubMed ID: 33526990
    [No Abstract]   [Full Text] [Related]  

  • 43. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
    Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G
    Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholesterol and Triglyceride Concentrations, COVID-19 Severity, and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
    Zinellu A; Paliogiannis P; Fois AG; Solidoro P; Carru C; Mangoni AA
    Front Public Health; 2021; 9():705916. PubMed ID: 34490188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Abnormal liver chemistries as a predictor of COVID-19 severity and clinical outcomes in hospitalized patients.
    Krishnan A; Prichett L; Tao X; Alqahtani SA; Hamilton JP; Mezey E; Strauss AT; Kim A; Potter JJ; Chen PH; Woreta TA
    World J Gastroenterol; 2022 Feb; 28(5):570-587. PubMed ID: 35316959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of tests used to screen patients with liver disorders.
    Scheig R
    Prim Care; 1996 Sep; 23(3):551-60. PubMed ID: 8888344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A meta-analysis of the impact of COVID-19 on liver dysfunction.
    Wu ZH; Yang DL
    Eur J Med Res; 2020 Nov; 25(1):54. PubMed ID: 33148326
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac injury is associated with severe outcome and death in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies.
    Parohan M; Yaghoubi S; Seraji A
    Eur Heart J Acute Cardiovasc Care; 2020 Sep; 9(6):665-677. PubMed ID: 32567326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longitudinal progression of clinical variables associated with graded liver injury in COVID-19 patients.
    Lu JY; Anand H; Frager SZ; Hou W; Duong TQ
    Hepatol Int; 2021 Aug; 15(4):1018-1026. PubMed ID: 34268650
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.
    Sultan S; Altayar O; Siddique SM; Davitkov P; Feuerstein JD; Lim JK; Falck-Ytter Y; El-Serag HB;
    Gastroenterology; 2020 Jul; 159(1):320-334.e27. PubMed ID: 32407808
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated liver enzymes and cardiovascular mortality: a systematic review and dose-response meta-analysis of more than one million participants.
    Rahmani J; Miri A; Namjoo I; Zamaninour N; Maljaei MB; Zhou K; Cerneviciute R; Mousavi SM; Varkaneh HK; Salehisahlabadi A; Zhang Y
    Eur J Gastroenterol Hepatol; 2019 May; 31(5):555-562. PubMed ID: 30614883
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver chemistries in severe or non-severe cases of COVID-19: A systematic review and meta-analysis.
    Dong X; Zeng DY; Xing QQ; Hong MZ; Pan JS
    World J Hepatol; 2022 Dec; 14(12):2012-2024. PubMed ID: 36618330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Liver enzyme alteration: a guide for clinicians.
    Giannini EG; Testa R; Savarino V
    CMAJ; 2005 Feb; 172(3):367-79. PubMed ID: 15684121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of COVID-19 on liver abnormalities: a systematic review and meta-analysis.
    Bzeizi K; Abdulla M; Mohammed N; Alqamish J; Jamshidi N; Broering D
    Sci Rep; 2021 May; 11(1):10599. PubMed ID: 34012016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.
    Zhang H; Liao YS; Gong J; Liu J; Zhang H
    World J Gastroenterol; 2020 Aug; 26(31):4694-4702. PubMed ID: 32884226
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Clinical characteristics of liver damage in 30 patients with severe coronavirus disease 2019 in Sichuan area].
    Li T; Deng C; Du Q; Yue R; Lu S; Chen H; Guo Y; Huang X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):928-932. PubMed ID: 32912404
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum amyloid A concentrations, COVID-19 severity and mortality: An updated systematic review and meta-analysis.
    Zinellu A; Paliogiannis P; Carru C; Mangoni AA
    Int J Infect Dis; 2021 Apr; 105():668-674. PubMed ID: 33737133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver Injury and Dysfunction Associated with COVID-19: a Review Article.
    Yahia AIO
    Clin Lab; 2022 Jan; 68(1):. PubMed ID: 35023684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of serum hepatic enzyme activities in different COVID-19 phenotypes.
    Liao FL; Peng DH; Chen W; Hu HN; Tang P; Liu YY; Luo Y; Yao T
    J Med Virol; 2021 Apr; 93(4):2365-2373. PubMed ID: 33314141
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum cortisol concentration and COVID-19 severity: a systematic review and meta-analysis.
    Amiri-Dashatan N; Koushki M; Parsamanesh N; Chiti H
    J Investig Med; 2022 Mar; 70(3):766-772. PubMed ID: 35058334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.